bosentan anhydrous has been researched along with Diarrhea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, Y; Endo, H; Hamaguchi, Y; Ihn, H; Kawaguchi, Y; Kuwana, M; Motegi, SI; Sumida, T; Takehara, K; Tanaka, S | 1 |
| Lambova, S; Müller-Ladner, U | 1 |
1 trial(s) available for bosentan anhydrous and Diarrhea
| Article | Year |
|---|---|
Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open-label study.
Topics: Administration, Oral; Adult; Aged; Anemia; Arthralgia; Bosentan; Constipation; Diarrhea; Endothelin Receptor Antagonists; Female; Fingers; Herpes Zoster; Humans; Japan; Liver; Liver Function Tests; Male; Middle Aged; Prospective Studies; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Treatment Outcome; Wound Healing | 2017 |
1 other study(ies) available for bosentan anhydrous and Diarrhea
| Article | Year |
|---|---|
Connective tissue diseases: Treatment of digital ulcers in systemic sclerosis.
Topics: Bosentan; Diarrhea; Endothelin Receptor Antagonists; Fingers; Hand; Humans; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Transaminases; Treatment Outcome | 2011 |